MSLN significantly enhanced the BM abilities of NSCLC cells by facilitating the expression and activation of MET through the c-Jun N-terminal kinase signaling pathway, which allowed tumor cells to disrupt tight junctions and the integrity of the BBB. The gene discussed is MSLN; the disease is non-small cell lung carcinoma.